688235 百济神州
已收盘 06-08 15:00:00
资讯
新帖
简况
每周股票复盘：百济神州（688235）股东Amgen持股比例被动稀释至16.70%
证券之星 · 06-07 01:36
每周股票复盘：百济神州（688235）股东Amgen持股比例被动稀释至16.70%
百济神州(06160)：授出受限制股份单位
智通财经 · 06-05
百济神州(06160)：授出受限制股份单位
6月2日百济神州跌5.88%，万家行业优选LOF基金重仓该股
证券之星 · 06-02
6月2日百济神州跌5.88%，万家行业优选LOF基金重仓该股
百济神州跌5.88%，浦银国际证券二个月前给出“买入”评级，目标价236.00元
证券之星 · 06-02
百济神州跌5.88%，浦银国际证券二个月前给出“买入”评级，目标价236.00元
百济神州（688235）披露持股5%以上股东权益变动触及1%刻度的提示性公告，6月1日股价下跌3.8%
证券之星 · 06-01
百济神州（688235）披露持股5%以上股东权益变动触及1%刻度的提示性公告，6月1日股价下跌3.8%
百济神州安泰适在华获批用于小细胞肺癌二线治疗
南方财经网 · 05-29
百济神州安泰适在华获批用于小细胞肺癌二线治疗
百济神州替雷利珠单抗获加拿大及魁北克省卫生技术评估机构正面报销建议，用于一线鼻咽癌治疗
美股速递 · 05-28
百济神州替雷利珠单抗获加拿大及魁北克省卫生技术评估机构正面报销建议，用于一线鼻咽癌治疗
本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨
新浪基金 · 05-28
本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨
上药控股与百济神州举行战略合作签约仪式
人民财讯 · 05-28
上药控股与百济神州举行战略合作签约仪式
中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通
智通财经 · 05-25
中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通
智谱、MiniMax，有望加入恒生科技指数
市场资讯 · 05-22
智谱、MiniMax，有望加入恒生科技指数
百济神州美股盘前涨超10%
每日经济新闻 · 05-20
百济神州美股盘前涨超10%
港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期
智通财经 · 05-20
港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期
生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%
金吾财讯 · 05-19
生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%
大行集体看涨百济神州(06160)， Q1业绩印证长期投资价值
智通财经 · 05-19
大行集体看涨百济神州(06160)， Q1业绩印证长期投资价值
5月18日百济神州跌5.09%，万家行业优选LOF基金重仓该股
证券之星 · 05-18
5月18日百济神州跌5.09%，万家行业优选LOF基金重仓该股
百济神州正在接近生命周期的一次切换
蓝鲸财经 · 05-18
百济神州正在接近生命周期的一次切换
美股中概股盘前涨跌互现，百度、阿里巴巴涨1%
每日经济新闻 · 05-18
美股中概股盘前涨跌互现，百度、阿里巴巴涨1%
百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂
智通财经 · 05-14
百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂
百济神州Beqalzi™ (Sonrotoclax)获美国FDA批准，成为首个且唯一用于R/R套细胞淋巴瘤的Bcl2抑制剂
美股速递 · 05-14
百济神州Beqalzi™ (Sonrotoclax)获美国FDA批准，成为首个且唯一用于R/R套细胞淋巴瘤的Bcl2抑制剂
加载更多
公司概况
公司名称：
百济神州有限公司
所属行业：
医药制造业
上市日期：
2021-12-15
主营业务：
百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是抗肿瘤类药物。
发行价格：
192.60
{"stockData":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":214.57,"timestamp":1780902000000,"preClose":220.18,"halted":0,"volume":2886620,"delay":0,"changeRate":-0.0255,"floatShares":114999999,"shares":1542000000,"eps":2.0518,"marketStatus":"已收盘","change":-5.61,"latestTime":"06-08 15:00:00","open":215.17,"high":222,"low":213.61,"amount":626000000,"amplitude":0.0381,"askPrice":214.74,"askSize":7,"bidPrice":214.57,"bidSize":2,"shortable":0,"etf":0,"ttmEps":2.0518,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780968600000},"marketStatusCode":5,"adr":0,"adjPreClose":220.18,"symbolType":"stock_kcb","openAndCloseTimeList":[[1780882200000,1780889400000],[1780894800000,1780902000000]],"highLimit":242.2,"lowLimit":198.16,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1541583805,"isCdr":false,"pbRate":10.01,"roa":"--","peRate":104.576469,"roe":"5.05%","epsLYR":1.03,"committee":0.398374,"marketValue":330778000000,"turnoverRate":0.0251,"status":1,"afterMarket":{"amount":0,"volume":0,"close":214.57,"buyVolume":0,"sellVolume":0,"time":1780904038866,"indexStatus":"已收盘 06-08 15:30:00","preClose":220.18},"hkstockBrief":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":163.1,"timestamp":1780906142010,"preClose":163,"halted":0,"volume":12434292,"delay":0,"premium":"-34.19"},"floatMarketCap":24687000000},"requestUrl":"/m/hq/s/688235/","defaultTab":"news","newsList":[{"id":"2641122476","title":"每周股票复盘：百济神州（688235）股东Amgen持股比例被动稀释至16.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641122476","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641122476?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:36","pubTimestamp":1780767371,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，百济神州报收于220.18元，较上周的243.9元下跌9.73%。本周，百济神州6月1日盘中最高价报248.88元。百济神州当前最新总市值3393.9亿元，在化学制药板块市值排名1/150，在两市A股市值排名40/5206。公司公告汇总百济神州有限公司持股5%以上股东Amgen Inc.因公司发行美国存托股份导致持股比例被动稀释，持股数量未变，仍为246,269,426股，持股比例由17.01%下降至16.70%，权益变动触及1%刻度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2328871848.SGD","BK1583","688235","06160","LU1251922891.USD","LU1303224171.USD","LU1719994722.HKD","LU0588546209.SGD","LU0307460666.USD","LU1770034418.SGD","BK1588","BK0239","BK1500","LU1969619763.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2641829119","title":"百济神州(06160)：授出受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2641829119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641829119?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:12","pubTimestamp":1780650777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年6月1日，董事会薪酬委员会根据2016期权及激励计划的条款授予381名承授人合共42,648股美国存托股份受限制股份单位。该等受限制股份单位相当于554,424股股份，约占本公告之日公司发行股份总数的0.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1969619763.USD","LU1719994722.HKD","BK1588","BK1500","LU0307460666.USD","LU1770034418.SGD","BK0239","688235","BK4585","BK1161","BK4139","LU1303224171.USD","LU0588546209.SGD","BK4526","BK4588","06160","ONC","BK1583","LU2328871848.SGD","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915411","title":"6月2日百济神州跌5.88%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915411?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:32","pubTimestamp":1780389170,"startTime":"0","endTime":"0","summary":"证券之星消息，6月2日百济神州跌5.88%，收盘报220.82元，换手率4.99%，成交量5.75万手，成交额12.79亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共107家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。万家行业优选LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1251922891.USD","LU1303224171.USD","BK0239","LU1969619763.USD","688235","160916","LU2328871848.SGD","BK1500","06160","LU1719994722.HKD","LU0588546209.SGD","LU1770034418.SGD","BK1583","BK1588","BK1161","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915197","title":"百济神州跌5.88%，浦银国际证券二个月前给出“买入”评级，目标价236.00元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915197?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:32","pubTimestamp":1780389156,"startTime":"0","endTime":"0","summary":"今日百济神州跌5.88%，收盘报220.82元。2026年3月9日，浦银国际证券研究员阳景,胡泽宇发布了对百济神州的研报《四季度收入符合预期，2026年催化剂丰富》，该研报对百济神州给出“买入”评级，认为其目标价为236.0元，研报发布时股价为238.49元，预期涨幅为1.04%。此外，东吴证券研究员朱国广，中邮证券研究员盛丽华,陈灿近期也对该股发布了研报，同样给出“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","06160","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640957252","title":"百济神州（688235）披露持股5%以上股东权益变动触及1%刻度的提示性公告，6月1日股价下跌3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640957252","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640957252?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:05","pubTimestamp":1780322737,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，百济神州报收于234.62元，较前一交易日下跌3.8%，最新总市值为3616.48亿元。该股当日开盘241.3元，最高248.88元，最低233.3元，成交额达12.42亿元，换手率为4.49%。近日，百济神州有限公司发布《关于持股5%以上股东权益变动触及1%刻度的提示性公告》。公告显示，公司持股5%以上股东Amgen Inc.因公司发行美国存托股份导致持股比例被动稀释，持股数量未变，仍为246,269,426股，持股比例由17.01%下降至16.70%，权益变动触及1%刻度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100040484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06160","LU1770034418.SGD","688235","LU0307460666.USD","LU1719994722.HKD","LU1969619763.USD","BK1161","LU2328871848.SGD","BK1583","LU1251922891.USD","BK1588","BK0239","BK1500","LU1303224171.USD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639644366","title":"百济神州安泰适在华获批用于小细胞肺癌二线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2639644366","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639644366?lang=zh_cn&edition=full","pubTime":"2026-05-29 14:18","pubTimestamp":1780035480,"startTime":"0","endTime":"0","summary":"南方财经5月29日电，百济神州宣布，安泰适?（注射用塔拉妥单抗）获得国家药品监督管理局（NMPA）新增适应症批准，用于既往接受过1种系统性治疗（包括含铂化疗）失败的广泛期小细胞肺癌（ES-SCLC）成人患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605293754345695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1303224171.USD","688235","06160","LU1719994722.HKD","BK1583","ONC","BK1588","LU1770034418.SGD","LU1251922891.USD","LU2328871848.SGD","BK4588","BK4139","LU0588546209.SGD","BK4526","LU1969619763.USD","BK1500","BK0239","LU0307460666.USD","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155844890","title":"百济神州替雷利珠单抗获加拿大及魁北克省卫生技术评估机构正面报销建议，用于一线鼻咽癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1155844890","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155844890?lang=zh_cn&edition=full","pubTime":"2026-05-28 18:06","pubTimestamp":1779962782,"startTime":"0","endTime":"0","summary":"百济神州宣布，其创新药物替雷利珠单抗（Tevimbra）用于一线治疗鼻咽癌的适应症，已获得加拿大药品管理局（CDA-AMC）及魁北克省卫生技术评估机构（INESSS）的正面报销建议。这一积极进展标志着该药物在加拿大公共卫生体系内的可及性迈出关键一步，有望惠及更多患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638196657","title":"本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨","url":"https://stock-news.laohu8.com/highlight/detail?id=2638196657","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638196657?lang=zh_cn&edition=full","pubTime":"2026-05-28 14:09","pubTimestamp":1779948540,"startTime":"0","endTime":"0","summary":"5月28日，港股深度调整，恒指一度跌逾2%。港股通创新药大幅走低，权重龙头集体飘绿，康方生物、百济神州跌逾2%，信达生物、中国生物制药跌超3%。 100%创新药研发标的——港股通创新药ETF华宝午后下探3.68%，现跌2.99%，连续4日下行，场内价格再创上市以来新低。 拉长时间看，港股通创新药自去年9月进入阶段调整期，至今已超8个月，港股通创新药ETF华宝标的指数区间跌幅已超过30%，当前位置或接近本轮调整底部区间，配置性价比凸显。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-05-28/doc-inhzmpqs0236306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0348767384.USD","LU0561508036.HKD","IE00B5MMRT66.SGD","LU2399975544.HKD","BK1574","BK1588","LU0634319403.HKD","LU0417516738.SGD","LU1794554557.SGD","BK4588","LU0348783233.USD","LU1251922891.USD","06978","BK4526","LU0588546209.SGD","LU0417516902.SGD","LU1770034418.SGD","BK4139","LU2476274720.SGD","LU0348784397.USD","BK4585","BK1161","LU0348825331.USD","LU0540923850.HKD","LU2488822045.USD","LU0348827113.USD","BK1583","ONC","LU0417516571.SGD","LU0348766576.USD","688235","09926","06160","BK1500","LU1719994722.HKD","VXUS","LU2778985437.USD","LU1720050803.USD","LU2328871848.SGD","LU2476274308.USD","LU0348735423.USD","159992","BK0239","520880","LU1969619763.USD","IE00B543WZ88.USD","LU1303224171.USD","IE00BPRC5H50.USD","LU1961090484.USD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2638630243","title":"上药控股与百济神州举行战略合作签约仪式","url":"https://stock-news.laohu8.com/highlight/detail?id=2638630243","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638630243?lang=zh_cn&edition=full","pubTime":"2026-05-28 08:32","pubTimestamp":1779928320,"startTime":"0","endTime":"0","summary":"人民财讯5月28日电，据上药控股消息，5月27日下午，上药控股与百济神州举行战略合作签约仪式，双方在医药健康领域的深度合作由此迈入全新发展阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283751977154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1303224171.USD","688235","06160","LU1719994722.HKD","BK1583","ONC","BK1588","LU1770034418.SGD","LU1251922891.USD","LU2328871848.SGD","BK4588","BK4139","LU0588546209.SGD","BK4526","LU1969619763.USD","BK1500","BK0239","LU0307460666.USD","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638585985","title":"中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2638585985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638585985?lang=zh_cn&edition=full","pubTime":"2026-05-25 13:59","pubTimestamp":1779688785,"startTime":"0","endTime":"0","summary":"参照恒指公司的行业分类，此次恒指调整后，对于医疗保健业的覆盖度从38.8%提升至44.3%，对于工业的覆盖度从54.3%提升至56.0%。该行根据此次恒生综合指数调整情况、结合港股通纳入的额外要求，预计6只或符合港股通纳入范围。此次进入恒生综合指数的Minimax-W由于其同股不同权性质，需额外满足上市满6个月及20个交易日的条件，因此不会在本次6月调整中进入港股通，预计于8月纳入港股通。若后续满足市值与成交额要求，有望于8月纳入港股通。","market":"hk","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7ab48a17674d5845193952fa54058c28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445467.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03423","LU1719994722.HKD","LU0348827113.USD","HSCEI","09088","BK1151","HSI","02837","LU1808992512.USD","09926","02600","513600","ONC","03115","LU0307460666.USD","BK1161","688235","LU1251922891.USD","82800","LU0561508036.HKD","LU1961090484.USD","BK1175","02828","LU0417516902.SGD","07288","LU2778985437.USD","07500","03037","LU0588546209.SGD","83115","HSCI","LU2399975544.HKD","BK1592","LU1969619763.USD","HSTECH","03033","IE00B543WZ88.USD","07552","BK1589","LU1303224171.USD","LU1770034418.SGD","BK1191","BK1513","601600","02800","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","06160","02513","BK1568","HHImain","LU0417516738.SGD","LU1720050803.USD","BK1574","LU0348783233.USD","LU0348767384.USD","82828","BK1583","LU0634319403.HKD","LU0348784397.USD","BK1588","LU0348735423.USD","LU0417516571.SGD","03416","07300","07226","07588","LU2476274720.SGD","03088","LU0540923850.HKD","LU0348766576.USD","03692","00100","BK1500","03417","LU2476274308.USD","LU2328871848.SGD","03032","BK1117","07200","MCHmain","09115","09067","LU1794554557.SGD","LU0348825331.USD","LU2488822045.USD","HK0000286598.CNH","02833","03419","01519","03067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637399348","title":"智谱、MiniMax，有望加入恒生科技指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2637399348","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637399348?lang=zh_cn&edition=full","pubTime":"2026-05-22 13:38","pubTimestamp":1779428280,"startTime":"0","endTime":"0","summary":" 恒生指数公司将于今日收市后公布季度检讨结果。 市场焦点集中在智谱、MiniMax这两只AI概念股，有望被纳入恒生科技指数及综合指数。 根据市场分析，智谱、MiniMax因近期市值大幅上升，已成为纳入恒生科技指数的最有力候选。 至于摩根士丹利此前预期，智谱、及MiniMax将于6月纳入恒生科技指数，合计权重约5%至7%，或带动12.5亿至17.5亿美元的被动资金流入，而纳入港股通可能会在6个月内将内地持股比例提升至自由流通股的9%至20%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-22/doc-inhytyys6180072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03423","LU1719994722.HKD","LU0348827113.USD","09088","HSI","02837","LU2279701549.SGD","09926","513600","ONC","03115","LU0307460666.USD","LU1251922891.USD","BK1161","688235","82800","LU0823426308.USD","LU0561508036.HKD","LU1961090484.USD","BEKE","IE0034224299.USD","01818","LU0417516902.SGD","BK1198","LU2778985437.USD","07500","LU0650527681.SGD","03037","LU0588546209.SGD","83115","LU0708994859.HKD","LU2399975544.HKD","BK1592","LU1969619763.USD","HSTECH","03033","IE00B543WZ88.USD","07552","LU1303224171.USD","LU1770034418.SGD","BK1097","02800","IE00B5MMRT66.SGD","LU0128525929.USD","IE00BPRC5H50.USD","06160","02513","HHImain","LU0417516738.SGD","LU1720050803.USD","BK1574","YUMC","LU0348783233.USD","LU0029864427.USD","LU0348767384.USD","02423","BK1583","09987","LU0634319403.HKD","LU0348784397.USD","BK1588","BK1233","LU0348735423.USD","LU0417516571.SGD","07300","07226","LU2476274720.SGD","03088","LU0540923850.HKD","LU0348766576.USD","00100","BK1500","LU1267930573.SGD","03417","LU2476274308.USD","LU2328871848.SGD","03032","LU0594300419.USD","BK1117","BK1544","LU0823426480.USD","07200","MCHmain","LU0310800379.SGD","09115","LU0228659784.USD","09067","LU1794554557.SGD","LU0348825331.USD","MHImain","LU2488822045.USD","02833","03419","03067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636140728","title":"百济神州美股盘前涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636140728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636140728?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:12","pubTimestamp":1779264777,"startTime":"0","endTime":"0","summary":"百济神州美股盘前涨超10%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605203743484856.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743484856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","BK1161","LU2328871848.SGD","BK4139","BK0239","06160","LU1770034418.SGD","LU0307460666.USD","BK4526","LU1251922891.USD","LU1303224171.USD","688235","BK4585","BK1588","LU1969619763.USD","BK1583","ONC","LU1719994722.HKD","BK1500","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636145813","title":"港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2636145813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636145813?lang=zh_cn&edition=full","pubTime":"2026-05-20 13:58","pubTimestamp":1779256684,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州涨近3%，截至发稿，涨2.23%，报178.7港元，成交额4.67亿港元。此前，百济神州披露26Q1业绩，中金指出，收入15.13亿美元，同比增长35%，其中产品收入14.87亿美元，同比增长34%，GAAP净利润2.27亿美元，同比增加2.26亿美元，销售收入符合该行预期，净利润超该行预期，主因费用控制较好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","ONC","06160","BK1161","BK4139","LU0307460666.USD","BK4588","LU1719994722.HKD","LU1770034418.SGD","688235","LABU","LU1303224171.USD","BK1500","LU0588546209.SGD","LU1969619763.USD","BK4585","LU2328871848.SGD","VXUS","LU1251922891.USD","BK1588","BK1583","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885146","title":"生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636885146?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:46","pubTimestamp":1779155169,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普涨，截至发稿，药明合联 涨5.24%，科伦博泰生物涨4.01%，百济神州涨2.17%，诺诚健华涨2.00%，药明生物涨1.58%，康诺亚-B涨1.35%，金斯瑞生物科技涨1.12%。消息面上，中邮证券研究表示，26年有望迎来BD和重点项目数据读出的双重催化，国产创新药全球性竞争力提升逻辑不断强化。建议关注确定性高、BD预期扰动相对小的标的。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0708995583.HKD","LU0823426308.USD","BK4588","BK1161","BK1576","BK1574","LU0456846285.SGD","06990","06160","LU1770034418.SGD","LU0516422366.SGD","HK0000306701.USD","LU0307460666.USD","LU0417516738.SGD","LU1719994722.HKD","BK1589","BK1141","LU1251922891.USD","09969","LU1242518931.SGD","LU1303224171.USD","LU3063872942.SGD","LU0039217434.USD","LU1688375341.USD","688235","IE00B0JY6N72.USD","02269","SG9999002562.SGD","BK1588","LU0320764599.SGD","LU0359202008.SGD","399441","02268","LU0417516902.SGD","SG9999014674.SGD","LU0348825331.USD","161726","LU0052750758.USD","LU0043850808.USD","LU0359201612.USD","XBI","BK1583","LU0181495838.USD","ONC","HK0000320264.USD","LU0588546209.SGD","LU0516422440.USD","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636883343","title":"大行集体看涨百济神州(06160)，\tQ1业绩印证长期投资价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2636883343","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636883343?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:10","pubTimestamp":1779153033,"startTime":"0","endTime":"0","summary":"GAAP口径下，百济神州Q1季度全球总收入达15.13亿美元，同比增长35.5%，超出此前FactSet一致预期的14.4亿美元。26Q1季度，百济神州产品收入达15亿美元，同比增长34%。该行在将百济神州维持“买入”评级的同时，将其美股目标价由430美元进一步上调至453美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06160","LU1719994722.HKD","BK4526","BK4588","LU0588546209.SGD","LU1251922891.USD","BK0239","ONC","LU1770034418.SGD","BK4139","LU1969619763.USD","BK1588","BK1583","BK1500","688235","LU2328871848.SGD","LU0307460666.USD","LU1303224171.USD","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636025578","title":"5月18日百济神州跌5.09%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636025578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636025578?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:28","pubTimestamp":1779092926,"startTime":"0","endTime":"0","summary":"证券之星消息，5月18日百济神州跌5.09%，收盘报239.2元，换手率4.02%，成交量4.62万手，成交额11.12亿元。重仓百济神州的前十大公募基金请见下表：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为321.19。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共107家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。该公募基金现任基金经理为黄兴亮。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800022970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","LU0588546209.SGD","BK1161","LU1251922891.USD","LU1770034418.SGD","LU0307460666.USD","160916","LU2328871848.SGD","BK0239","BK1588","LU1303224171.USD","BK1583","06160","LU1969619763.USD","LU1719994722.HKD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636023442","title":"百济神州正在接近生命周期的一次切换","url":"https://stock-news.laohu8.com/highlight/detail?id=2636023442","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636023442?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:13","pubTimestamp":1779092018,"startTime":"0","endTime":"0","summary":"文｜锦缎市场整体下跌时，百济神州再次成为资金流出的对象。BTK叙事的延伸一个常见的解读是，百济神州又增加了一款新药。从单品到矩阵的跃迁，本质上是公司生命周期的一次切换。索托克拉的获批，是百济神州在这条路径上迈出的一步。泽布替尼代表了百济神州的过去和现在。百济神州拿到了一张关键牌，但牌局远未到收官的阶段。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779076618818843533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","BK1161","BK4585","LU1719994722.HKD","BK4139","BK1583","LU1251922891.USD","LU1969619763.USD","06160","BK1588","LU2328871848.SGD","BK1500","BK4588","LU0588546209.SGD","ONC","LU0307460666.USD","BK4526","LU1770034418.SGD","688235","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636702309","title":"美股中概股盘前涨跌互现，百度、阿里巴巴涨1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636702309","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636702309?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:02","pubTimestamp":1779091355,"startTime":"0","endTime":"0","summary":"5月18日，美股中概股盘前涨跌互现，百度、阿里巴巴涨1%，京东涨0.4%，拼多多持平，网易跌0.3%，百济神州跌0.8%，携程跌1%，理想汽车跌10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605183740446853.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740446853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FLCH","LU0797268264.HKD","LU0251143458.SGD","LU1515016050.SGD","LU1769817096.USD","LU0553294199.USD","LU1046421795.USD","BK4575","IE00BFMHRM44.USD","KBAB","LU2148611432.USD","BK4538","BK4558","LU0918141705.HKD","LU1051768304.USD","BK4527","LU0918141887.USD","02823","LU0661504455.SGD","CWEB","06160","TCOM","BABW","BK4122","LU0949170772.SGD","LU0348814723.USD","BABO","BK4524","LU0067412154.USD","BK4585","LU0501845795.SGD","LU0651947912.USD","LU1267930227.SGD","ASHR","DRAG","09961","BK4565","BK4503","ALBmain","BK4502","IE00BF5LJ272.USD","LU0328353924.USD","BK4614","BK4552","LU1823568750.SGD","LU0880133367.SGD","LU2226246903.HKD","BBYY","BK4534","LU0173614495.USD","JD","LU1282648689.USD","BABX","BK4579","LU1242518857.USD","LU0052756011.USD","PDD","LU1003077747.HKD","02015","BK4612","LU0047713382.USD","LU0545039389.USD","LU1152091754.HKD","02843","ASHS","BK4543","BK4607","BK4535","YXI","BK4526","BK4533","82823","BK4077","BK4602","09618","LU1688375341.USD","FXP","BK4514","ONC","BK4574","BK4581","NTES","LU1115378108.SGD","LU0072913022.USD","LU1023057109.AUD","LU1105468828.SGD","LU0359201612.USD","XPP","LU1046422090.SGD","BK4587","HXC","LU0963586101.USD","MCHI","LU0979878070.USD","BABA","688235","LU0072462343.USD","LU1880383366.USD","LU0359202008.SGD","BK4550","82843","02822","LU1152091168.USD","BK4554","BK4531","LU1008478684.HKD","LI","82822","LU1048588211.SGD","LU1235294995.USD","LU0456842615.SGD","LU0287142896.SGD","LU1051769294.HKD","IE00B0JY6N72.USD","09888","LU1048596156.SGD","BK4504","09999","09988","BIDG","LU0128525689.USD","LU0348816934.USD","BABU","BK4505","LU0310800965.SGD","BK4548","LU0821914370.USD","LU0738911758.USD","BK4220","BIDU","BK4588","LU0106959298.USD","LU0640798160.USD","LU0651946864.USD","LU1242518931.SGD","KBDU","LU1769817179.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635936752","title":"百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2635936752","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635936752?lang=zh_cn&edition=full","pubTime":"2026-05-14 07:47","pubTimestamp":1778716032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，公司于2026年5月13日宣布百悦达获得美国食品药品监督管理局加速批准，用于治疗既往接受过至少两线系统治疗的复发或难治性(R/R)套细胞淋巴瘤成人患者。索托克拉是一款在BCL2靶点研发中具有基石性潜力的新一代BCL2抑制剂，其研发设计以增强BCL2抑制剂作用为目标，在分子效力和选择性方面进行了优化，且其药理学特性也有望改善用药的有效性、耐受性和便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1770034418.SGD","BK4139","LU0307460666.USD","BK1583","BK0239","BK1500","BK4526","LU1969619763.USD","06160","LABU","LU1303224171.USD","LU1251922891.USD","BK1588","ONC","LU1719994722.HKD","BK4585","BK4588","LU2328871848.SGD","BK1161","688235","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1113457800","title":"百济神州Beqalzi™ (Sonrotoclax)获美国FDA批准，成为首个且唯一用于R/R套细胞淋巴瘤的Bcl2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1113457800","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113457800?lang=zh_cn&edition=full","pubTime":"2026-05-14 01:28","pubTimestamp":1778693292,"startTime":"0","endTime":"0","summary":"百济神州旗下药物Beqalzi™ (Sonrotoclax)已获得美国食品药品监督管理局的批准，成为首个且唯一获批用于治疗复发或难治性套细胞淋巴瘤的Bcl2抑制剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780928052941,"stockEarnings":[{"period":"1week","weight":-0.0973},{"period":"1month","weight":-0.1081},{"period":"3month","weight":-0.0768},{"period":"6month","weight":-0.2115},{"period":"1year","weight":-0.0652},{"period":"ytd","weight":-0.1803}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0318},{"period":"3month","weight":-0.0234},{"period":"6month","weight":0.032},{"period":"1year","weight":0.1902},{"period":"ytd","weight":0.0148}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"百济神州有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"35235人(较上一季度增加6.53%)","perCapita":"3265股","listingDate":"2021-12-15","address":"c/o BeOne Medicines I GmbH, Aeschengraben 27, 4051Basel, Switzerland","registeredCapital":"15万元","survey":" 百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是抗肿瘤类药物。","listedPrice":192.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(688235)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(688235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,688235,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(688235)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(688235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}